Drag a card by its title · ⚙ to size, swap or remove

The company

Entrada Therapeutics, Inc.

TRDA · Nasdaq

Health CareBiotechnologyNot moving yet

TRDA stood above a rising 150-day average in 23 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 47.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 24
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $1.7M
Insider sales, 12 months: $26.6M
Officials’ trades on record: 0
Institutions holding: 124 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5

Sale orders, 12 months72

Buyers · sellers3 · 14

Who	Did	Shares	Traded
Mpm Bioventures 2014, L.p.10% owner	sold	28,837at $7.13	9 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	28,837at $7.13	9 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2014, L.p.10% owner	sold	192,500at $7.41	8 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	192,500at $7.41	8 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2014, L.p.10% owner	sold	38,500at $7.11	4 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	38,500at $7.11	4 Sep 2026filed 9 Sep 2026
Mpm Bioventures 2014, L.p.10% owner	sold	32,263at $7.17	3 Sep 2026filed 3 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	32,263at $7.17	3 Sep 2026filed 3 Sep 2026
Mpm Bioventures 2014, L.p.10% owner	sold	25,131at $7.19	2 Sep 2026filed 3 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	25,131at $7.19	2 Sep 2026filed 3 Sep 2026
Mpm Bioventures 2014, L.p.10% owner	sold	29,088at $7.06	1 Sep 2026filed 3 Sep 2026
Mpm Bioventures 2018, L.p.10% owner	sold	29,088at $7.06	1 Sep 2026filed 3 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders124+11 on the quarter

New · exited27 · 16

Reported value$208.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026	5,072,730$37.3M	00.0%
5AM Venture Management, LLCunchanged · filed 14 Aug 2026	4,056,379$29.9M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	2,583,333$19.0M	+224,540+9.5%
Merck & Co., Inc.new · filed 7 Aug 2026	1,739,768$12.8M	+1,739,768
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,269,634$9.3M	+13,621+1.1%
MPM BIOIMPACT LLCnew · filed 14 Aug 2026	1,253,053$9.2M	+1,253,053
TCG Crossover Management, LLCreduced · filed 14 Aug 2026	1,060,230$7.8M	-1,227,270−53.7%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026	954,419$7.0M	-80,363−7.8%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	763,959$5.6M	+244,603+47.1%
StepStone Group LPunchanged · filed 13 Aug 2026	761,277$5.6M	00.0%